Press Releases

• LUSTGARTEN FOUNDATION FLAGSHIP WALK INSPIRES COMMUNITY AND RAISES CRITICAL DOLLARS FOR PANCREATIC CANCER RESEARCHOctober 7, 2024
  24th Annual Long Island Walk presented by Northwell Health Cancer Institute draws over 2,000 supporters & raises more than $660,000 and counting in support of pancreatic cancer research  JONES BEACH, N.Y., Oct 07, 2024 – Long Island residents touched by pancreatic cancer gathered for a morning of hope, remembrance, and action at Sunday’s Walk for… Read more: LUSTGARTEN FOUNDATION FLAGSHIP WALK INSPIRES COMMUNITY AND RAISES CRITICAL DOLLARS FOR PANCREATIC CANCER RESEARCH
• The Lustgarten Foundation Announces Landmark Year of Fueling Cutting-Edge Pancreatic Cancer ResearchAugust 8, 2024
  UNIONDALE, NY, Aug 15, 2024 — The Lustgarten Foundation, the nation’s largest private funder of pancreatic cancer research, today announced a landmark year of funding, awarding ten new grants to researchers at seven leading institutions. These grants, totaling $10.7 million, support Lustgarten’s unique patient-centered mission which drives outcomes across three research pillars—early detection and interception,… Read more: The Lustgarten Foundation Announces Landmark Year of Fueling Cutting-Edge Pancreatic Cancer Research
• Lustgarten Clinical Accelerator Initiative (CAI) Recipients Announced July 29, 2024
  CAI grants awarded to Eric Christenson, MD, & Andrew Lowy, MD   WOODBURY, N.Y., July 30, 2024 — The Lustgarten Foundation has announced two new Dr. Robert F. Vizza Lustgarten Clinical Accelerator Initiative (CAI) grants awarded to Eric Christenson, MD, Assistant Professor, Johns Hopkins University School of Medicine, for his study “A pilot study comparing neoadjuvant… Read more: Lustgarten Clinical Accelerator Initiative (CAI) Recipients Announced 
• Lustgarten Foundation Appoints Two New Board Members June 12, 2024
  Richard Barakat, MD, and Aaron Kantoff join the Lustgarten Foundation Board of Directors   Woodbury, New York, June 11, 2024 – The Lustgarten Foundation, the largest private funder of pancreatic cancer research in the world, today announced the appointment of two new board members: Richard Barakat, MD, and Aaron Kantoff. Dr. Barakat is a world-renowned surgeon… Read more: Lustgarten Foundation Appoints Two New Board Members 
• Announcing the 2024 Lustgarten Equity, Accessibility, and Diversity (LEAD) Project Grant May 30, 2024
  Fiyinfolu Balogun, MD, PhD, Assistant Professor, Memorial Sloan Kettering Cancer Center, Awarded 2024 LEAD Project Grant   WOODBURY, N.Y., May 30, 2024 — The Lustgarten Foundation has announced that the 2024 Lustgarten Equity, Accessibility, and Diversity (LEAD) Project grant will be awarded to Fiyinfolu Balogun, MD, PhD, Assistant Professor, Memorial Sloan Kettering Cancer Center, for his… Read more: Announcing the 2024 Lustgarten Equity, Accessibility, and Diversity (LEAD) Project Grant 
• Announcing the 2024 Innovation and Collaboration Program Grant Recipient May 28, 2024
  Linda Resar, MD, Professor of Medicine, Oncology, and Pathology, Johns Hopkins University, Awarded 2024 Innovation and Collaboration Program Grant   WOODBURY, N.Y., May 27, 2024 — The Lustgarten Foundation announced today that the 2024 Innovation and Collaboration Program grant will be awarded to Linda Resar, MD, Professor of Medicine, Oncology, and Pathology, Johns Hopkins University for… Read more: Announcing the 2024 Innovation and Collaboration Program Grant Recipient 
• The Lustgarten Foundation Receives $500,000 Gift from The Warren Alpert Foundation May 1, 2024
  The remarkable gift will support the LABS (Lustgarten Advancing Breakthrough Science) Program.  WOODBURY, N.Y., May 1, 2024 — The Lustgarten Foundation today announced a remarkable $500,000 donation from The Warren Alpert Foundation. The generous gift will support the LABS (Lustgarten Advancing Breakthrough Science) Program, which encourages researchers to explore promising avenues for understanding and treating… Read more: The Lustgarten Foundation Receives $500,000 Gift from The Warren Alpert Foundation 
• 14th Annual Lustgarten Foundation New York City Walk, Sponsored by Northwell Health, Raises Critical Funds for Pancreatic Cancer Research  April 22, 2024
  Over 300 pancreatic cancer supporters united at Hudson River Park’s Pier 84 in New York City  New York, N.Y., Apr 22, 2024 — Over 300 pancreatic cancer supporters united at Hudson River Park’s Pier 84 in Manhattan on April 21 for a morning of hope, remembrance, and action to raise critical funds for the Lustgarten… Read more: 14th Annual Lustgarten Foundation New York City Walk, Sponsored by Northwell Health, Raises Critical Funds for Pancreatic Cancer Research  
• New FDA Approval Brings More Treatment Options in Metastatic Disease February 14, 2024
  With thanks and appreciation to our contributing partner, Let’s Win Pancreatic Cancer. The U.S. Food and Drug Administration has approved irinotecan liposome (ONIVYDE) in combination with oxaliplatin, fluorouracil, and leucovorin, for the frontline treatment of metastatic pancreatic adenocarcinoma.   The combo, dubbed NALIRIFOX, has been shown to improve overall survival for a disease that has far… Read more: New FDA Approval Brings More Treatment Options in Metastatic Disease 
• Lustgarten Foundation receives $550,000 grant towards next phase of Organoids for Personalized Therapy (OPT) ProjectFebruary 13, 2024
  From devastation to dedication, Gail Coleman is committed to supporting personalized medicine in pancreatic cancer research. WOODBURY, NY, February 14, 2024 – Gail Coleman, a nine-year supporter of the Lustgarten Foundation, has generously committed a three-year gift totaling $550,000 to support the Organoids for Personalized Therapy (OPT) Project at the LABS (Lustgarten Advancing Breakthrough Science)… Read more: Lustgarten Foundation receives $550,000 grant towards next phase of Organoids for Personalized Therapy (OPT) Project
• 2024 Walks AnnouncedFebruary 5, 2024
  Find a Lustgarten Walk for Pancreatic Cancer Research near you!
• Unintentional weight loss is associated with an increase in the risk of a cancer diagnosis within the coming yearJanuary 31, 2024
  According to a Lustgarten-funded study from Dana-Farber Cancer Institute WOODBURY, NY, January 31, 2024 — Last week, the Journal of the American Medical Association published results from a Lustgarten-funded study from the LABS (Lustgarten Advancing Breakthrough Science) Program site at Dana-Farber Cancer Institute, led by Brian Wolpin, M.D., MPH, Director of the Gastrointestinal Cancer Center… Read more: Unintentional weight loss is associated with an increase in the risk of a cancer diagnosis within the coming year
• The Lustgarten Foundation Receives $1.5 Million Gift from The Bern Schwartz Family FoundationJanuary 26, 2024
  The generous gift will support the LABS (Lustgarten Advancing Breakthrough Science) Program site at the Salk Institute for Biological Studies.  WOODBURY, N.Y., Jan 26, 2024 — The Lustgarten Foundation today announced an extraordinary $1.5 million gift from The Bern Schwartz Family Foundation. The generous donation will support the LABS (Lustgarten Advancing Breakthrough Science) Program site… Read more: The Lustgarten Foundation Receives $1.5 Million Gift from The Bern Schwartz Family Foundation
• The Lustgarten Foundation hosts Seeing Beyond, Lustgarten’s inaugural pancreatic cancer research symposium November 20, 2023
  Research pioneers, experts, and early career investigators unite LIVE in New York City for Seeing Beyond, honoring the organization’s 25th anniversary year.  NEW YORK, NY, November 20, 2023 – On Wednesday, November 15, 2023, The Lustgarten Foundation hosted their inaugural pancreatic cancer research symposium, Seeing Beyond. The Foundation is the largest private funder of pancreatic… Read more: The Lustgarten Foundation hosts Seeing Beyond, Lustgarten’s inaugural pancreatic cancer research symposium 
• Lustgarten Foundation Flagship Walk Inspires Community and Raises Critical Dollars for Pancreatic Cancer ResearchOctober 3, 2023
  23rd Annual Long Island Walk presented by Northwell Health Cancer Institute draws over 2,000 supporters & raises over $700,000 and counting in support of pancreatic cancer research. JONES BEACH, N.Y., Oct 01, 2023 – Long Island residents touched by pancreatic cancer gathered for a morning of hope, remembrance, and action at Sunday’s Walk for Pancreatic… Read more: Lustgarten Foundation Flagship Walk Inspires Community and Raises Critical Dollars for Pancreatic Cancer Research
• The Cancer Research Institute and the Lustgarten Foundation Announce INSPIRE Partnership to Jointly Support Pancreatic Cancer Immunotherapy ResearchSeptember 18, 2023
  (NEW YORK) – The Cancer Research Institute (CRI) and the Lustgarten Foundation have announced a new partnership focused exclusively on supporting pancreatic cancer immunotherapy research.    The partnership, INSPIRE (Integrated Network for Supporting Pancreatic Cancer Immunotherapy Research Efforts), will encompass the established and ongoing adaptive platform trial, REVOLUTION, evaluating first-line chemo-immunotherapy treatment combinations for patients… Read more: The Cancer Research Institute and the Lustgarten Foundation Announce INSPIRE Partnership to Jointly Support Pancreatic Cancer Immunotherapy Research
• The Lustgarten Foundation Announces Extraordinary Year of Research Grants Fueling Bold and Innovative Pancreatic Cancer ResearchAugust 2, 2023
  The Lustgarten Foundation, the nation’s largest private funder of pancreatic cancer research, today announced a remarkable year of funding, awarding 17 new grants to researchers at 13 leading institutions. These grants, totaling $23 million, support Lustgarten’s collaborative, science-focused strategy, which drives outcomes across three research pillars—early detection, new drug development, and personalized medicine. With the… Read more: The Lustgarten Foundation Announces Extraordinary Year of Research Grants Fueling Bold and Innovative Pancreatic Cancer Research
• Lustgarten Foundation Announces 2023 Innovation and Collaboration Program GrantsJuly 24, 2023
  Kacper Rogala, DPhil, MRes, Stanford University School of Medicine & David Kashatus, PhD, University of Virginia School of Medicine, Awarded 2023 Innovation and Collaboration Program Grants   WOODBURY, N.Y., July 24, 2023 — The Lustgarten Foundation announced today that the 2023 Innovation and Collaboration Program grants will be awarded to Kacper Rogala, DPhil, MRes, Assistant Professor… Read more: Lustgarten Foundation Announces 2023 Innovation and Collaboration Program Grants
• Lustgarten Foundation Announces the Appointment of Two New Board MembersJuly 13, 2023
  Selwyn M. Vickers, MD, FACS, and Scott Penberthy, PhD, MS, join the Lustgarten Foundation Board of Directors  Woodbury, New York, July 13, 2023 – The Lustgarten Foundation, the nation’s largest private funder of pancreatic cancer research, today announced the appointment of two new board members: Selwyn M. Vickers, MD, FACS, and Scott Penberthy, PhD, MS.… Read more: Lustgarten Foundation Announces the Appointment of Two New Board Members
• Lustgarten-funded clinical trial yields promising results as the Journal Nature publishes findings: Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer.June 1, 2023
  In May 2023, the Journal Nature published promising results from a study funded by the Pancreatic Cancer Collective (PCC), a partnership between the Lustgarten Foundation and Stand Up To Cancer. This study was the culmination of years of research leading to the critical discovery that long-term pancreatic cancer survivors have specific immune responses that the… Read more: Lustgarten-funded clinical trial yields promising results as the Journal Nature publishes findings: Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer.
• 2023 Lustgarten Foundation-AACR Career Development Awardees AnnouncedMay 15, 2023
  WOODBURY, NY – At the American Association for Cancer Research (AACR) Annual Meeting 2023, The Lustgarten Foundation and the AACR presented the Lustgarten Foundation-AACR Career Development Awards for Pancreatic Cancer Research, in Honor of Ruth Bader Ginsburg and John Robert Lewis to Christina M. Ferrer, PhD, from the University of Maryland, Baltimore, Maryland, and Ashley… Read more: 2023 Lustgarten Foundation-AACR Career Development Awardees Announced
• 2023 Lustgarten Equity, Accessibility, and Diversity (LEAD) Project Grant Recipients AnnouncedMay 12, 2023
  WOODBURY, N.Y., May 9, 2023 — The Lustgarten Foundation has announced that the 2023 Lustgarten Equity, Accessibility, and Diversity (LEAD) Project grants will be awarded to Karyn Goodman, MD, MS, Vice Chair of Radiation Oncology and Associate Director of Clinical Research at Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, for her study… Read more: 2023 Lustgarten Equity, Accessibility, and Diversity (LEAD) Project Grant Recipients Announced
• Andrew Rakeman, PhD, Lustgarten Foundation Vice President of Research, and Elizabeth Jaffee, MD, Lustgarten Foundation Chief Medical Advisor and Deputy Director, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Attend The Alma Mater Studiorum/Lustgarten Foundation Lecture in Bologna, Italy April 25, 2023
  Bologna, Italy – On April 3, 2023, Andrew Rakeman, PhD, and Elizabeth Jaffee, MD, attended the first ever Alma Mater Studiorum/Lustgarten Foundation Lecture in Bologna, Italy at the University of Bologna, led by Professor Riccardo Casadei, MD, Chief of the Pancreatic and Endocrine Surgical Division. The lecture entitled “Pancreatic Cancer: The Commitment of Breakthrough Science… Read more: Andrew Rakeman, PhD, Lustgarten Foundation Vice President of Research, and Elizabeth Jaffee, MD, Lustgarten Foundation Chief Medical Advisor and Deputy Director, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Attend The Alma Mater Studiorum/Lustgarten Foundation Lecture in Bologna, Italy 
• 13th Annual Lustgarten Foundation New York City Walk, Sponsored by Northwell Health, Raises Critical Funds for Pancreatic Cancer ResearchApril 17, 2023
  Over 500 pancreatic cancer supporters united at Hudson River Park’s Pier 84 in New York City  New York, N.Y. —Over 500 pancreatic cancer supporters united at Hudson River Park’s Pier 84 in Manhattan on April 16 for a morning of hope, remembrance, and action to raise critical funds for the Lustgarten Foundation. Since its inception… Read more: 13th Annual Lustgarten Foundation New York City Walk, Sponsored by Northwell Health, Raises Critical Funds for Pancreatic Cancer Research
• The Lustgarten Foundation Announces Grants to Elliot Fishman, MD, Johns Hopkins University School of Medicine & Alan Yuille, PhD, Johns Hopkins Whiting School of Engineering to Advance Pancreatic Cancer Detection EffortsMarch 15, 2023
  WOODBURY, N.Y., Mar 01, 2023 — The Lustgarten Foundation announced today that two grants will be awarded to Elliot Fishman, MD, Johns Hopkins University School of Medicine for his study FELIX 2.0. The Integration of AI into the Early Detection and Management of Pancreatic Cancer with Novel AI Algorithms and Advanced Data Analysis and Alan Yuille, PhD, Johns Hopkins Whiting… Read more: The Lustgarten Foundation Announces Grants to Elliot Fishman, MD, Johns Hopkins University School of Medicine & Alan Yuille, PhD, Johns Hopkins Whiting School of Engineering to Advance Pancreatic Cancer Detection Efforts
• 22nd ANNUAL WINTER BASH RAISES CRITICAL FUNDS FOR THE LUSTGARTEN FOUNDATION  February 17, 2023
  All Donations Fund Pancreatic Cancer Research    MSG Entertainment, MSG Sports, and AMC Networks Hosted Fundraiser   at Tao Downtown in New York City Featuring DJ Rumor and the Radio City Rockettes  NEW YORK, NY, February 17, 2023 – On Wednesday, February 15th, MSG Entertainment (NYSE: MSG), MSG Sports (NYSE: MSGS), and AMC Networks (NASDAQ: AMCX) hosted… Read more: 22nd ANNUAL WINTER BASH RAISES CRITICAL FUNDS FOR THE LUSTGARTEN FOUNDATION  
• Lustgarten Foundation Receives $424,000 Grant Establishing the Gail V. Coleman and Kenneth M. Bruntel Organoids for Personalized Therapy ProjectJanuary 9, 2023
  Devastated by the loss of her husband Kenneth Bruntel to pancreatic cancer, Gail Coleman is laser-focused on funding research offering hope and better treatment options for patients with metastatic cancer. Coleman knows the devastation of a pancreatic cancer diagnosis all too well, having also lost her 66-year-old mother followed by her 80-year-old father to the… Read more: Lustgarten Foundation Receives $424,000 Grant Establishing the <strong>Gail V. Coleman and Kenneth M. Bruntel Organoids for Personalized Therapy Project</strong>
• The Lustgarten Foundation awards over $6M to investigate early events in pancreatic cancerDecember 7, 2022
  WOODBURY, N.Y., Dec 06, 2022 — The Lustgarten Foundation announced the awarding of grants to Alison Klein, Ph.D., M.H.S., Co-Leader, Cancer Prevention and Control Program (CPC) Professor of Oncology at Johns Hopkins University School of Medicine for her study Identifying high-risk pancreatic cancer genes using Long Read Sequencing and Laura Wood, M.D., Ph.D., Associate Professor… Read more: The Lustgarten Foundation awards over $6M to investigate early events in pancreatic cancer
• The Lustgarten Foundation Announces Mandar Muzumdar, MD, Yale Cancer Center & Andrew Lowy, MD, University of California San Diego, Moores Cancer Center to Receive 2022 Innovation and Collaboration Program Grants  November 4, 2022
  WOODBURY, N.Y., Nov 04, 2022 — The Lustgarten Foundation announced today that the 2022 Innovation and Collaboration Program grants will be awarded to Mandar Muzumdar, MD, Co-Director of Pancreas Program, Center for Gastrointestinal Cancers at Smilow Cancer Hospital and Yale Cancer Center for his study Dietary oleic acid reprograms pancreatic lipid metabolism to drive cancer… Read more: The Lustgarten Foundation Announces Mandar Muzumdar, MD, Yale Cancer Center & Andrew Lowy, MD, University of California San Diego, Moores Cancer Center to Receive 2022 Innovation and Collaboration Program Grants  
• Louis W. Fortunoff Family Fun Night at Adventureland attracts more than 650 supporters and raises approximately $300,000 benefiting the Lustgarten Foundation October 13, 2022
  10 years after the passing of Louis W. Fortunoff from pancreatic cancer, family, friends, and loved ones gather to raise funds for the advancement of pancreatic cancer research.  FARMINGDALE, N.Y., Oct 12, 2022 /PRNewswire/ — Over the weekend, over 650 people gathered at Adventureland Amusement Park for the Louis W. Fortunoff Family Fun Night. Hosted… Read more: Louis W. Fortunoff Family Fun Night at Adventureland attracts more than 650 supporters and raises approximately $300,000 benefiting the Lustgarten Foundation 
• Lustgarten Foundation Flagship Walk Inspires Community and Raises Critical Dollars for Pancreatic Cancer ResearchOctober 3, 2022
  22nd Annual Long Island Walk presented by Northwell Health Cancer Institute draws over 1,100 supporters amid wet weather & raises 700,000 dollars and counting in support of pancreatic cancer research. WOODBURY, N.Y., Oct 03, 2022 /PRNewswire/ — Long Island residents touched by pancreatic cancer gathered for a day of remembrance, action, and hope at Sunday’s… Read more: Lustgarten Foundation Flagship Walk Inspires Community and Raises Critical Dollars for Pancreatic Cancer Research
• Lustgarten Foundation Announced Grant Programs to Inspire and Diversify Talent in Pancreatic Cancer ResearchSeptember 27, 2022
  Two Grant Programs Now Accepting Request for Applications, through October 18, 2022  WOODBURY, N.Y., Sept 26, 2022 — The Lustgarten Foundation announced that it is supporting two grant programs intended to inspire and diversify talent in pancreatic cancer research: Lustgarten Foundation-AACR Career Development Award for Pancreatic Cancer Research and Lustgarten Foundation-Swim Across America-AACR Pancreatic Cancer… Read more: Lustgarten Foundation Announced Grant Programs to Inspire and Diversify Talent in Pancreatic Cancer Research
• Jen Jen Yeh, MD Announced as Inaugural Recipient of LEAD GrantSeptember 16, 2022
  WOODBURY, N.Y., Sept 16, 2022 /PRNewswire/ — The Lustgarten Foundation announced today that the Lustgarten Equity, Accessibility, and Diversity (LEAD) Project’s inaugural grant will be awarded to Jen Jen Yeh, MD, Professor & Vice Chair of Research, Surgery, Division of Oncology Professor, Pharmacology Member, Lineberger Comprehensive Cancer Center for her PROmoting CLinicAl TrIal EngageMent for… Read more: Jen Jen Yeh, MD Announced as Inaugural Recipient of LEAD Grant
• Legislator Joshua A. Lafazan Shines Spotlight on the Lustgarten Foundation’s Mission to Cure Pancreatic CancerAugust 15, 2022
  (WOODBURY, N.Y.) – Nassau County Legislator Joshua A. Lafazan (D-Woodbury) met with members of the Lustgarten Foundation and presented them with a citation to honor the important research they are leading for pancreatic cancer—a devastating disease with a five-year survival rate of just 11%. The Lustgarten Foundation has raised more than $250 million to support… Read more: Legislator Joshua A. Lafazan Shines Spotlight on the Lustgarten Foundation’s Mission to Cure Pancreatic Cancer
• The Lustgarten Foundation Receives 13th Consecutive  Charity Navigator 4-Star RatingMay 19, 2022
  Recognition places Lustgarten in top 1% of nonprofits evaluated by the watchdog organization.   WOODBURY, NY – The Lustgarten Foundation believes research is fundamental. That’s why 100% of donations fund pancreatic cancer research. This singular focus on transforming pancreatic cancer into a curable disease, combined with the Foundation’s commitment to financial health, accountability and transparency, has… Read more: The Lustgarten Foundation Receives 13th Consecutive  Charity Navigator 4-Star Rating
• Pancreatic Cancer Collective Announces New PSA Campaign with Marlon Wayans and Tiffany HaddishNovember 11, 2021
  The PSA aims to raise awareness for pancreatic cancer clinical trials. LOS ANGELES –The Pancreatic Cancer Collective, an initiative of the Lustgarten Foundation and Stand Up To Cancer® (SU2C), announced today the launch of a new public service announcement (PSA) campaign. In collaboration with SU2C Ambassadors – actor and comedian Marlon Wayans, and actress and… Read more: Pancreatic Cancer Collective Announces New PSA Campaign with Marlon Wayans and Tiffany Haddish
• Pancreatic Cancer Collective Announces New PSA Campaign with Keesha Sharp to Raise Awareness about Pancreatic Cancer Clinical TrialsNovember 11, 2021
  NEW YORK – The Pancreatic Cancer Collective, an initiative of the Lustgarten Foundation and Stand Up To Cancer (SU2C), announced today the launch of a new public service announcement (PSA) campaign, in collaboration with SU2C Ambassador and actress, writer and director Keesha Sharp, to raise awareness for pancreatic cancer research. The campaign launches with a… Read more: Pancreatic Cancer Collective Announces New PSA Campaign with Keesha Sharp to Raise Awareness about Pancreatic Cancer Clinical Trials
• Pancreatic Cancer Experts Available in Response to Alex Trebek DeathNovember 8, 2021
  The Lustgarten Foundation offers in-depth insight into life-threatening disease Like fans around the world, we were saddened to learn of the death today of Alex Trebek, 80, from pancreatic cancer. By openly sharing his cancer battle, Alex became a powerful voice in raising awareness of pancreatic cancer and providing hope for people affected by pancreatic… Read more: Pancreatic Cancer Experts Available in Response to Alex Trebek Death
• Lustgarten Foundation Raises More than $18 million for Pancreatic Cancer Research at Long Island EventOctober 4, 2021
  21st Annual Long Island Walk for Research sponsored by Northwell Health More than 2,000 Long Islanders touched by pancreatic cancer were finally able to come back together at Jones Beach in Wantagh on Sunday, Oct. 3 for a day of hope, awareness and fundraising for pancreatic cancer research. The Lustgarten Foundation’s annual Walk for Pancreatic… Read more: Lustgarten Foundation Raises More than $18 million for Pancreatic Cancer Research at Long Island Event
• Lustgarten Foundation kicks off first in-person event with New York City Pancreatic Cancer Research Walk sponsored by Northwell HealthJune 28, 2021
  Hundreds of walkers touched by pancreatic cancer united at Hudson River Park’s Pier 84 in New York City on Sunday, June 27 Woodbury, N.Y. —Hundreds of walkers touched by pancreatic cancer united at Hudson River Park’s Pier 84 in New York City on Sunday, June 27 for a day of hope, awareness and funding for… Read more: Lustgarten Foundation kicks off first in-person event with New York City Pancreatic Cancer Research Walk sponsored by Northwell Health
• The Lustgarten Foundation and the AACR Honor Two American Icons Lost to Pancreatic Cancer with New Career Development Awards for ResearchersApril 12, 2021
  The Lustgarten Foundation and the American Association for Cancer Research (AACR) have established two new career development awards for both early-career female and under-represented pancreatic cancer researchers, representing a generous commitment of the Lustgarten Foundation of up to $1.8 million. The awards will honor the extraordinary lives and legacies of United States Supreme Court Justice… Read more: The Lustgarten Foundation and the AACR Honor Two American Icons Lost to Pancreatic Cancer with New Career Development Awards for Researchers
• New Clinical Trial Studies Pancreatic Cancer Tumor Traits to Uncover Better Treatment OptionsMarch 30, 2021
  NEW YORK – March 30, 2021 – A new team of pioneering pancreatic cancer researchers has been formed to predict which treatments might work best for individual pancreatic cancer patients based on the molecular traits of tumors. The Pancreatic Cancer Convergence Dream Team is funded by the Pancreatic Cancer Collective, an initiative of the Lustgarten… Read more: New Clinical Trial Studies Pancreatic Cancer Tumor Traits to Uncover Better Treatment Options
• The Lustgarten Foundation Appoints New CEOJanuary 15, 2021
  Linda Tantawi to Lead National Expansion.  WOODBURY, NY – The Lustgarten Foundation today announced the appointment of Linda Tantawi as Chief Executive Officer. As CEO, Tantawi will expand the organization’s national presence to achieve its mission of finding a cure for pancreatic cancer. Since 1998, the Lustgarten Foundation has been at the forefront of advancements… Read more: The Lustgarten Foundation Appoints New CEO
• Two Scientists Named to Receive Inaugural Lustgarten Foundation-AACR Career Development Awards for Pancreatic Cancer Research in Honor of Ruth Bader Ginsburg and John Robert LewisJanuary 7, 2021
  PHILADELPHIA – Dannielle Engle, PhD, of the Salk Institute for Biological Studies, and Avery D. Posey, PhD, of the Perelman School of Medicine at the University of Pennsylvania, have been announced at the American Association for Cancer Research (AACR) Annual Meeting 2021 as the inaugural recipients of the Lustgarten Foundation-AACR Career Development Awards for Pancreatic… Read more: Two Scientists Named to Receive Inaugural Lustgarten Foundation-AACR Career Development Awards for Pancreatic Cancer Research in Honor of Ruth Bader Ginsburg and John Robert Lewis
• Lustgarten Foundation’s New York Pancreatic Cancer Research Walks Go Virtual with Sponsorship from Northwell Health Cancer InstituteJune 16, 2020
  Woodbury, N.Y., —Several thousand participants hit the streets throughout the New York metropolitan area in support of the Lustgarten Foundation a year ago. Times have dramatically changed since the coronavirus pandemic began, but the mission is no less critical: ending pancreatic cancer On Sunday, July 12, thousands of walkers across Manhattan, Brooklyn and Westchester will… Read more: Lustgarten Foundation’s New York Pancreatic Cancer Research Walks Go Virtual with Sponsorship from Northwell Health Cancer Institute
• Lustgarten Foundation Chief Scientist Dr. David Tuveson Installed as President of the American Association for Cancer Research (AACR)April 21, 2020
  David A. Tuveson, MD, PhD, FAACR, Chief Scientist of the Lustgarten Foundation and Director of the Cold Spring Harbor Laboratory Cancer Center, was inaugurated as President of the American Association for Cancer Research (AACR), the world’s oldest and largest professional association related to cancer research. David A. Tuveson, MD, PhD, FAACR, Chief Scientist of the… Read more: Lustgarten Foundation Chief Scientist Dr. David Tuveson Installed as President of the American Association for Cancer Research (AACR)
• The Pancreatic Cancer Collective Extends Four Research Teams in $16 Million Push for New TherapiesMarch 5, 2020
  PHILADELPHIA — The Pancreatic Cancer Collective, the strategic partnership of Lustgarten Foundation and Stand Up To Cancer (SU2C), has awarded additional funding of up to $16 million to four teams of top researchers as part of its “New Therapies Challenge Grants,” the American Association for Cancer Research (AACR), Scientific Partner of SU2C, announced today. The additional… Read more: The Pancreatic Cancer Collective Extends Four Research Teams in $16 Million Push for New Therapies
• Northwell, Lustgarten expand sponsorship to fight pancreatic cancerFebruary 19, 2020
  NEW HYDE PARK, NY – In its second year of collaboration with the Lustgarten Foundation, Northwell Health Cancer Institute announced today that it will be the exclusive hospital sponsor for the Foundation’s four New York metropolitan area walks and other fundraising events in 2020. Northwell will again team with Lustgarten in supporting its community walks,… Read more: Northwell, Lustgarten expand sponsorship to fight pancreatic cancer
• Lustgarten Foundation Announces Change in Board LeadershipFebruary 7, 2020
  Andrew Lustgarten assumes helm of father’s namesake organization as Chairman of the Board of Directors Dr. Vizza “passes the baton” after more than 20 years leading the Foundation New York, NY – The Lustgarten Foundation, the largest private funder of pancreatic cancer research in the world, is pleased to announce today that Andrew Lustgarten will… Read more: Lustgarten Foundation Announces Change in Board Leadership
• American Cancer Society Releases New Statistics for Pancreatic Cancer IncidenceJanuary 7, 2020
  Data Demonstrates the Need for Lustgarten-Funded Early Detection Research WOODBURY, N.Y. —The American Cancer Society (ACS) recently released its annual Cancer Facts & Figures 2020 report, which indicates an increase in the incidence of pancreatic cancer in 2020 and demonstrated the continued need for early detection research. The report takes an in-depth look at different… Read more: American Cancer Society Releases New Statistics for Pancreatic Cancer Incidence

About Lustgarten Foundation  

The Lustgarten Foundation funds the world’s preeminent pancreatic cancer researchers, driving the pursuit of bold and innovative science toward earlier detection, better treatments and transforming pancreatic cancer into a curable disease. The Foundation is a catalyst—Lustgarten-funded science has been a driving force in every major advancement in pancreatic cancer research since 1998. We believe time is everything for pancreatic cancer patients and their families, so we fund research where creative risks yield high rewards to accelerate and expand life-saving treatment options. And we believe in the power of community. Lustgarten programs and events provide people affected by pancreatic cancer a voice and a place to create hope, together. The Lustgarten Foundation is the world’s largest private funder of pancreatic cancer research and 100% of all donations fuel the research to advance understanding of this complex, devastating and historically underfunded cancer. For more information, visit lustgarten.org.  

Follow us on social @LustgartenFDN: Facebook, Instagram Twitter and Youtube.
And @the-lustgarten-foundation on LinkedIn.